Gilead Sciences
GILD
1,598 hedge funds and large institutions have $86.8B invested in Gilead Sciences in 2016 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 653 increasing their positions, 725 reducing their positions, and 112 closing their positions.
10% less repeat investments, than reductions
Existing positions increased: 653 | Existing positions reduced: 725
1.4% less ownership
Funds ownership: 80.3% → 78.9% (-1.4%)
2% less funds holding
Funds holding: 1,632 → 1,598 (-34)
30% less call options, than puts
Call options by funds: $1.38B | Put options by funds: $1.98B
30% less funds holding in top 10
Funds holding in top 10: 188 → 131 (-57)
33% less first-time investments, than exits
New positions opened: 75 | Existing positions closed: 112
35% less capital inflows, than outflows
Capital inflows: $4.82B | Capital outflows: $7.37B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$300M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$234M |
| 3 |
Goldman Sachs
New York
|
+$199M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$172M |
| 5 |
BlackRock Advisors
Wilmington,
Delaware
|
+$159M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$917M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$506M |
| 3 |
Egerton Capital (UK)
London,
United Kingdom
|
-$277M |
| 4 |
Barclays
London,
United Kingdom
|
-$247M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$230M |
GILD Hedge Fund Activity: Q2 2016 in Review
1,598 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2016, worth a combined $86.8B — down 12% from $98.2B a quarter earlier.
Sellers outnumbered buyers: 112 funds closed out of GILD and 75 opened new positions — a net loss of 37 holders — while 725 trimmed existing stakes and 653 added.
The largest buyer was Capital World Investors, adding an estimated $300M. The largest seller was T. Rowe Price Associates, cutting an estimated $917M.
- 1,598 institutional investors held Gilead Sciences (GILD) as of Q2 2016, down from 1,632 in Q1 2016.
- Funds reported $86.8B of Gilead Sciences stock for Q2 2016, down 12% quarter-over-quarter.
- 75 funds opened new Gilead Sciences positions in Q2 2016 and 112 closed out, a net change of -37 holders.
- The largest Gilead Sciences buyer in Q2 2016 was Capital World Investors, an estimated $300M added.
- The largest Gilead Sciences seller in Q2 2016 was T. Rowe Price Associates, an estimated $917M sold.
Based on aggregated 13F filings for Q2 2016.